Literature DB >> 8190279

The thalamic ataxia syndrome.

D H Solomon1, R J Barohn, C Bazan, J Grissom.   

Abstract

We identified 10 patients with contralateral ataxia and hemisensory loss following unilateral thalamic lesions. Seven patients had ischemic infarcts, and three had hemorrhages. Hemiparesis, when present, was only a transient finding, whereas ataxia, dysmetria, dysdiadochokinesia, rebound, and hemisensory loss persisted. Two patients had cerebellar outflow tremor. Another developed a severe Déjerine-Roussy pain syndrome. Four patients had lesions of the dominant hemisphere, and two had visual field deficits. None had mutism, aphasia, or astasia. On radiographic evaluation, all patients had lesions in the mid to posterior thalamus, a localization consistent with a lesion of the dentatorubrothalamic and ascending sensory pathways into the thalamus. The thalamic ataxia syndrome has a distinct localizing value that is distinguishable from the ataxic hemiparesis syndrome. Strokes occurring in the ventral lateral and posterior nuclei of the thalamus produce the clinical picture of contralateral "cerebellar" dysfunction and sensory loss with only transient weakness.

Entities:  

Mesh:

Year:  1994        PMID: 8190279     DOI: 10.1212/wnl.44.5.810

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Involvement of the human ventrolateral thalamus in olfaction.

Authors:  S Zobel; T Hummel; J Ilgner; A Finkelmeyer; U Habel; D Timmann; J B Schulz; M Kronenbuerger
Journal:  J Neurol       Date:  2010-07-17       Impact factor: 4.849

2.  Deep brain stimulation of the globus pallidus internus or ventralis intermedius nucleus of thalamus for Holmes tremor.

Authors:  Jairo Alberto Espinoza Martinez; Gabriel J Arango; Erich Talamoni Fonoff; Thomas Reithmeier; Oscar Andrés Escobar; Luciano Furlanetti; G Rene Alvarez Berastegui; Fabio Eduardo Fernandes da Silva; William Omar Contreras Lopez
Journal:  Neurosurg Rev       Date:  2015-05-20       Impact factor: 3.042

3.  Contribution of the ventrolateral thalamus to the locomotion-related activity of motor cortex.

Authors:  Irina N Beloozerova; Vladimir Marlinski
Journal:  J Neurophysiol       Date:  2020-08-12       Impact factor: 2.714

4.  Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings.

Authors:  Heike Jacobi; Till-Karsten Hauser; Paola Giunti; Christoph Globas; Peter Bauer; Tanja Schmitz-Hübsch; László Baliko; Alessandro Filla; Caterina Mariotti; Maria Rakowicz; Perine Charles; Pascale Ribai; Sandra Szymanski; Jon Infante; Bart P C van de Warrenburg; Alexandra Dürr; Dagmar Timmann; Sylvia Boesch; Roberto Fancellu; Rafal Rola; Chantal Depondt; Ludger Schöls; Elzbieta Zdzienicka; Jun-Suk Kang; Susanne Ratzka; Berry Kremer; Dennis A Stephenson; Béla Melegh; Massimo Pandolfo; Sophie Tezenas du Montcel; Johannes Borkert; Jörg B Schulz; Thomas Klockgether
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

5.  Isolated astasia in acute infarction of the supplementary-motor area.

Authors:  Yuko Wada; Yo Nishimura
Journal:  BMJ Case Rep       Date:  2010-08-06

6.  Neuronal activity reorganization in motor cortex for successful locomotion after a lesion in the ventrolateral thalamus.

Authors:  Irina N Beloozerova
Journal:  J Neurophysiol       Date:  2021-11-03       Impact factor: 2.714

7.  Disconnection syndromes of basal ganglia, thalamus, and cerebrocerebellar systems.

Authors:  Jeremy D Schmahmann; Deepak N Pandya
Journal:  Cortex       Date:  2008-05-23       Impact factor: 4.027

8.  Isolated ataxia after pure left insular cortex infarction.

Authors:  Li-Min Liou; Yuh-Cherng Guo; Chiou-Lian Lai; Chin-Ling Tsai; Gim-Thean Khor
Journal:  Neurol Sci       Date:  2009-10-06       Impact factor: 3.307

9.  Crossed cerebellar diaschisis in acute isolated thalamic infarction detected by dynamic susceptibility contrast perfusion MRI.

Authors:  Alex Förster; Hans U Kerl; Johannes Goerlitz; Holger Wenz; Christoph Groden
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.